Summary
Researchers identified a new diterpenoid, scoparicol E, extracted from Scoparia dulcis, which demonstrated potential to protect pancreatic islet cells against apoptosis. In experiments with mice, scoparicol E reduced MLD-STZ induced hyperglycemia and increased insulin levels, showing a significant antidiabetic effect. The mechanism of action involves modulation of the Bax/Bcl-2/Caspase-3 pathway, crucial for cellular apoptosis. Western blot analysis confirmed that scoparicol E inhibited Caspase-3 activation and cytochrome c release, restoring mitochondrial membrane potential and protecting MIN6 cells from cell death. These findings reinforce the traditional use of Scoparia dulcis in folk medicine for diabetes treatment, although further research is needed to fully elucidate its mechanisms of action.
Key points
- The new diterpenoid scoparicol E demonstrated reduced hyperglycemia in diabetic mice.
- Scoparicol E inhibited the Bax/Bcl-2/Caspase-3 pathway, a central mechanism in cellular apoptosis.
- Intervention with scoparicol E restored mitochondrial membrane potential and prevented cytochrome c release.
- The study utilized methods such as CCK-8 and flow cytometry to evaluate the antiapoptotic activity of the compound.
- The results suggest that scoparicol E may be a promising agent for the protection of pancreatic islet cells.
✦ For you
If you are looking for ways to support pancreatic health, consider including Scoparia dulcis in your diet, either in the form of tea or supplement. Additionally, observe how your body reacts to different foods and avoid those that cause glucose spikes. Maintaining an active lifestyle and a balanced diet is also essential. If you have persistent symptoms, seek a qualified healthcare professional.
For practitionersExpand
In clinical practice, the use of Scoparia dulcis may be considered for patients with diabetes, especially those showing signs of pancreatic function impairment. Evaluate the possibility of including the new diterpenoid scoparicol E in formulas, observing the patient's response. It is important to monitor glucose levels and pancreatic function during treatment.